News & Events

2011 Press Releases

Eidogen-Sertanty Enhances iProtein iPad App

San Diego, CA (January 6, 2011) - Eidogen-Sertanty, Inc., a San Diego-based computational drug discovery solutions provider, announced today the release of a major update to iProtein. The iProtein iPad app has been enhanced with new functionality including Molecular Materials Informatics' very powerful molecular editor (Embedded MMDS). Users of iProtein can now benefit from iPad native molecular editing to rapidly draw and search protein bound ligands.

Other enhancements to iProtein include multitasking support, retrieval of protein and model coordinates, retrieval of sites through ligand names, and site-similarity searching across co-complexes within the proteome. For more complex site-similarity searching, users require a subscription to Eidogen-Sertanty's Target Informatics Platform (TIP).


iProtein is among the suite of Eidogen-Sertanty's iPhone and iPad applications which include iProtein, iKinase Universal, iKinasePro Universal, iOncology, Rxn101, Yield101, SPRESImobile, and alternative medicine related apps iYoga108 and iYoga108 for the iPhone. For more information, please see Welcome to iProtein, the proteome in the sky.


For more information, please contact:

Steve Muskal

About Eidogen-Sertanty, Inc.

Eidogen-Sertanty is a privately held company that is dedicated to helping scientists discover new medicines with innovative software technology and knowledgebases. To find out more about Eidogen-Sertanty please visit

About Molecular Materials Informatics

Molecular Materials Informatics provides cheminformatics software for mobile computing environments. The flagship product is the Mobile Molecular DataSheet (MMDS), which combines a unique and innovative chemical diagram sketcher with informatics features for organizing molecular datasheets, accessing chemically aware webservices, and sharing data using network resource. To find out more about Molecular Materials Informatics, please visit